Application of Bioimpedance Vector Analysis in Neonates

Healthy Clinical Trial

Official title:

Application of Bioimpedance Vector Analysis in Neonates

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06188377
• Other study ID #: 2023-KY-154
• Status: Recruiting
• Start date: November 6, 2023
• Est. completion date: March 31, 2024

Study information

• Verified date: November 2023
• Source: Zhujiang Hospital
• Contact: Tian Zhichen, master
• Phone: +8613066385364
• Email: tianzhichen63[@]163.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The goal of this observational study is to learn about the distribution of bioimpedance vector of healthy neonates in China in health conditions. The main question it aims to answer are:whether the distribution of bioimpedance vector of healthy neonates in China is correspond to that in other countries.Participants will be measures by NUTRILAB impedance analyzer (Akern, Florence, Italy).

Description:

Data such as demographic data, maternal background, gestational age at birth, gestational history, weight and height, will be collected from medical records.Each day we will measure 3 newborns chosen by simple random sampling, for which we will use Excel function.Bioimpedance analysis will be performed according to the manufacturer's instructions within the first 24 hours of life, using a tetrapolar configuration of electrodes (at 400 μA and 50 kHz) with a NUTRILAB impedance analyzer (Akern, Florence, Italy). BIA data will be acquired when they are still, preferably in quiet sleep, avoiding contact between the upper limbs and trunk, and between the legs. Two outer distal adhesive electrodes will be placed on the dorsal surface of the right hand and foot, proximal to the metacarpal-phalangeal and metatarsal-phalangeal joints, and 2 inner electrodes will be placed proximally on the right fore-arm and pretibial region, leaving 5.5cm of free skin around the outer electrodes. The surface should have no skin lesions and will be cleaned with chlorhexidine solution. R and Xc values will be measured in triplicate in each infant, and the arithmetic mean will be used. The device will be calibrated every 20 evaluations(approximately once a week) using a resistor provided by the manufacturer. All the measurements will be performed at the nursery by the same investigator.We will use BIVA to analyse the result: the components of the impedance vector (R and Xc) will be normalized by the height (R/H [ohm/m] and Xc/H [ohm/m], respectively). PA is obtained from the arc-tangent ratio Xc:R. To transform it from radians to degrees, the result is multiplied by 180°/π。Using the RXc graph method the bivariate 95% confidence intervals (ellipses) of the mean vectors of the newborns will be established. From the bivariate normal distribution of R/H and Xc/H, the bivariate 95%, 75%, and 50% tolerance intervals will be drawn. We will use the Hotelling T2 test and univariate analysis (F test) by the BIVA software 2002 for the analysis of the CI for the comparison of the subject groups and for the analysis of tolerance intervals. The significance level is set at 0.05 in all tests.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 120
• Est. completion date: March 31, 2024
• Est. primary completion date: March 31, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A to 24 Hours

Eligibility

Inclusion Criteria:

1. Healthy term neonates of both sexes within 24 hours.

2. Neonates whose parents or guardians consent with the research.

Exclusion Criteria:

1. Infants with some disease and conditions that could interfere in the body composition (such as heart failure, blue light irradiation, sepsis, kidney injury, hepatic failure, transfusion) and newborns with congenital anomalies and/or genetic problems.

2. Neonates whose parents or guardians refuse to participate in the research.

Related Conditions & MeSH terms

• Healthy

Intervention

Device:
• measured by a impedance analyzer
the healthy chinese neonates will be measured by a impedance analyzer, and will be compared with that of other ethnicity whose data have been reported by literatures.

Locations

Country	Name	City	State
China	Zhujiang Hospital of Southern Medical University	Guangzhou	Guangdong

Sponsors (1)

Lead Sponsor	Collaborator
Zhujiang Hospital

Country where clinical trial is conducted

China, 

References & Publications (4)

Margutti AV, Monteiro JP, Camelo JS Jr. Reference distribution of the bioelectrical impedance vector in healthy term newborns. Br J Nutr. 2010 Nov;104(10):1508-13. doi: 10.1017/S000711451000245X. Epub 2010 Jul 2. — View Citation

Piccoli A, Fanos V, Peruzzi L, Schena S, Pizzini C, Borgione S, Bertino E, Chiaffoni G, Coppo R, Tato L. Reference values of the bioelectrical impedance vector in neonates in the first week after birth. Nutrition. 2002 May;18(5):383-7. doi: 10.1016/s0899- — View Citation

Savino F, Grasso G, Cresi F, Oggero R, Silvestro L. Bioelectrical impedance vector distribution in the first year of life. Nutrition. 2003 Jun;19(6):492-6. doi: 10.1016/s0899-9007(02)00947-4. — View Citation

Toffano RBD, Hillesheim E, Margutti AVB, Camelo Junior JS, Ferraz IS, Del Ciampo LA, Monteiro JP. Bioelectrical Impedance Vector Analysis in Healthy Term Infants in the First Three Months of Life in Brazil. J Am Coll Nutr. 2018 Feb;37(2):93-98. doi: 10.10 — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	the distribution of bioimpedance vector of chinese neonates	collect resistance and reactance of the subjects	till 2023-11-30